Point-of-care COPD diagnostics: biomarkers, sampling, paper-based analytical devices, and perspectives-Reference-Cited by-同舟云学术

Point-of-care COPD diagnostics: biomarkers, sampling, paper-based analytical devices, and perspectives

Published:2022 Issue:7 Volume:147 Page:1273-1293
ISSN:0003-2654
Container-title:The Analyst
language:en
Short-container-title:Analyst

Author:

He Guozhen¹²,Dong Tao²^ORCID,Yang Zhaochu¹,Branstad Are³,Huang Lan¹,Jiang Zhuangde¹

Affiliation:

1. Chongqing Key Laboratory of Micro-Nano Systems and Smart Transduction, Chongqing Key Laboratory of Colleges and Universities on Micro-Nano Systems Technology and Smart Transducing, Collaborative Innovation Center on Micro-Nano Transduction and Intelligent Eco-Internet of Things, Chongqing Academician and Expert Workstation, Chongqing Technology and Business University, Nan'an District, Chongqing 400067, China

2. Department of Microsystems (IMS), Faculty of Technology, Natural Sciences and Maritime Sciences, University of South-Eastern Norway, Postboks 235, 3603 Kongsberg, Norway

3. University of Southeast Norway (USN), School of Business, Box 235, 3603 Kongsberg, Norway

Abstract

COPD has become a major disease with great social and economic impacts. To enable point-of-care COPD diagnostics, paper-based analytical device is a promising candidate; however, it requires synergetic studies of biomarkers, biofluids, and sampling.

Funder

Chongqing Research Program of Basic Research and Frontier Technology

National Natural Science Foundation of China

Regionale forskningsfond Oslofjordfondet

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrochemistry,Spectroscopy,Environmental Chemistry,Biochemistry,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/AN/D1AN01702K

Reference220 articles.

1. The natural history of chronic airflow obstruction.